Top Markets
Coin of the day
Pharma Mar, S.A. Pharma Mar, S.A.

Pharma Mar, S.A.

PHM
Clasificación en acciones #7110
Pharma Mar, S.A., a biopharmaceutical firm established in 1986 and... Pharma Mar, S.A., a biopharmaceutical firm established in 1986 and headquartered in Madrid, Spain, is dedicated to the research, development, production, and global sale of marine-derived bioactive compounds. Its primary focus is oncology, with operations spanning Spain, Italy, Germany, Ireland, the wider European Union, the United States, and other international markets. The company's activities are organized into three key segments: Oncology, Diagnostics, and RNA interference. Among its developed and commercialized treatments are Yondelis, prescribed for soft tissue sarcomas and ovarian cancer; Aplidin, targeting multiple myeloma; and Zepzelca, used for patients with small cell lung cancer. Furthermore, Pharma Mar is advancing PM14, currently in Phase II clinical trials for various solid tumors. Beyond pharmaceuticals, the company manufactures and markets diagnostic kits and is involved in creating therapeutic drugs designed to reduce or silence gene expression.
Precio por acción
$99.16
Última sincronización: 2026-08-27
Capitalización bursátil
$1.72B
Cambio (1 día)
0.00%
Cambio (1 año)
2.52%
País
ES
Comercio Pharma Mar, S.A. (PHM)

Categoría

Historial de desdoblamientos de acciones de Pharma Mar, S.A. (PHM)
La acción Pharma Mar, S.A. (símbolo: PHM) tuvo un total de 0 desdoblamientos.
El desdoblamiento más reciente ocurrió el Aug 28, 2026.
Una acción PHM comprada antes de Aug 28, 2026 equivaldría hoy a 0 acciones PHM.
Lista de desdoblamientos de acciones
Año Desdoblamiento Multiplicador Multiplicador acumulado
Not enough data for the provided dates.
Desdoblamientos de acciones de empresas similares o competidoras
Empresa Número de desdoblamientos de acciones Multiplicador acumulado País
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH